L-tyrosine tert-butyl ester is a carboxyl-protected L-tyrosine derivative in which the C-terminal carboxylic acid is masked as a tert-butyl ester. The free base corresponds to molecular formula C₁₃H₁₉NO₃ and a molecular weight of 237.30 g/mol; the hydrochloride salt, C₁₃H₁₉NO₃·HCl, corresponds to 273.76 g/mol. The molecule retains an unprotected α-amino group and an unprotected phenolic hydroxyl, a combination that permits N-terminal coupling or peptide chain extension while the C-terminus remains blocked. Product model designations are supplier-specific; no universal model number exists across manufacturers. Specification sheets identify the product by chemical name, salt form, chromatographic purity, residual solvent content, and water content. Because the tert-butyl ester is base-stable but acid-labile, it is used where orthogonal carboxyl protection must survive basic Fmoc-deprotection conditions. The product is commonly supplied as the free base or hydrochloride; the free base is prone to carbamate formation in contact with atmospheric carbon dioxide, whereas the hydrochloride is ionically stabilized and easier to dispense under ambient dry conditions.

What Distinguishes Carboxyl Protection by a tert-Butyl Group from Lower Alkyl Esters?

Among tyrosine alkyl esters, the tert-butyl derivative differs primarily in the conditions required for carboxyl unmasking. Methyl and ethyl esters are removed by alkaline hydrolysis, typically with aqueous sodium hydroxide in methanol, whereas the tert-butyl ester is cleaved by acidolysis. In Fmoc-based peptide synthesis, the repeated use of piperidine in DMF removes the N-terminal Fmoc group by β-elimination; a methyl or ethyl ester at the C-terminus would be vulnerable to slow saponification under residual moisture, whereas the tert-butyl ester remains intact under these basic conditions. The acidolytic removal of the tert-butyl ester in TFA/DCM mixtures is compatible with side-chain protecting groups that are removed in the same step, but requires scavengers to trap the liberated tert-butyl cation and prevent C-alkylation or O-alkylation of the tyrosine phenolic hydroxyl. The acidolysis mechanism is carbocation-mediated; the tert-butyl group departs as a stabilized cation, which is why the cleavage rate is sensitive to acid concentration and solvent polarity. In contrast, methyl and ethyl esters require nucleophilic attack by water or hydroxide and are slower under anhydrous acidic conditions.

During solution-phase synthesis, L-tyrosine tert-butyl ester is dissolved in anhydrous dimethylformamide or dichloromethane and coupled with an N-protected amino acid using carbodiimide-mediated activation. With dicyclohexylcarbodiimide and 1-hydroxybenzotriazole, the free amino group forms an amide bond while the tert-butyl ester remains blocked. The unprotected phenolic hydroxyl can compete for acylation; therefore, coupling is performed at 0–5 °C or with a hindered tertiary amine to suppress phenolate formation. Batch-to-batch water content influences coupling efficiency: if residual water is not controlled, the carbodiimide is partially hydrolyzed and conversion decreases. On pilot-scale reactors, the ester is charged as a solid after Karl Fischer analysis per USP <921> or ISO 760 confirms residual water is below the process specification; pre-drying under vacuum at 25–30 °C is applied only when the measured water level would otherwise reduce active ester concentration. The hydrochloride salt may require one equivalent of a tertiary base to neutralize the salt before the coupling reaction proceeds; without neutralization, the free amino group remains protonated and unreactive toward activated carboxyl derivatives.

When Acidolytic Cleavage Is Run in Continuous-Flow Systems

Continuous-flow deprotection of the tert-butyl ester is performed with TFA in DCM at controlled residence times. The reaction releases isobutylene and tert-butyl trifluoroacetate, and the tyrosine side chain is prone to alkylation by the tert-butyl cation unless scavengers such as triisopropylsilane or anisole are included. Published data for this specific configuration is limited; however, the controlling variables are acid concentration, temperature, and residence time. Batch reactors require external cooling because mixing of TFA with DCM is exothermic; production vessels with jacket temperatures of −10 to 0 °C are used to limit side reactions. Continuous-flow equipment with back-pressure regulators maintains liquid-phase operation and permits residence times under 30 s for the ester-cleavage step. The resulting free acid is then precipitated or extracted into an aqueous buffer. Residual TFA is removed by co-evaporation with toluene or heptane on a rotary evaporator at bath temperature 35 °C; without co-evaporation, residual TFA lowers the pH of the next coupling step and can protonate basic residues in the product. In-line FTIR has been used in process development to monitor the disappearance of the ester carbonyl band near 1,730 cm⁻¹, but method transfer to production depends on PAT infrastructure.

Side-product formation during tert-butyl ester removal is governed by the fate of the tert-butyl cation. In the absence of scavengers, the cation can alkylate the electron-rich phenolic ring of tyrosine at the ortho positions, producing non-reversible impurities. Triisopropylsilane and anisole act as cation traps; triisopropylsilane is selected when the later product must remain in a volatile or extractable fraction, whereas anisole is less volatile and requires additional extraction. The addition of water at 2–5% v/v to the TFA cleavage mixture accelerates ester hydrolysis but can also promote peptide hydrolysis at longer residence times, so the water level is treated as a critical parameter in batch cleaning validation. On large-scale batch deprotections, the exotherm and the evolution of isobutylene require a reactor vent with flame arrestor and nitrogen purge; the maximum gas evolution rate is estimated from the ester concentration and the batch volume.

In fragment condensation strategies, L-tyrosine tert-butyl ester can act as a C-terminal fragment whose α-amino group is acylated by a side-chain-protected peptide acid. Because the tert-butyl ester suppresses epimerization at the C-terminal residue during activation, the compound is selected for sequences in which the C-terminal tyrosine must retain the L-configuration. The free phenolic hydroxyl is usually left unprotected during the coupling; however, if the peptide acid is activated as a pentafluorophenyl ester or an acid chloride, the phenol can be transiently acylated. In such cases, the crude mixture is treated with dilute aqueous bicarbonate at 0 °C to hydrolyze any phenolic ester without removing the tert-butyl ester. This selective hydrolysis is possible because the phenolic ester is more labile than the tert-butyl ester under mildly basic conditions.

Comparative Deprotection Boundaries Across Ester Forms

The selection of a tyrosine carboxyl protecting group depends on the downstream deprotection reagents and the sensitivity of the remaining molecule. The table below compares the main L-tyrosine esters used as intermediates.

The tert-butyl ester is therefore selected over methyl and ethyl esters when the synthesis includes repeated basic treatment. Benzyl ester also tolerates basic conditions but requires a hydrogenolysis step; this adds a heterogeneous catalyst and can be incompatible with sulfur-containing residues. Compared with the N-protected analogue Boc-Tyr-OtBu, the free amino group of L-tyrosine tert-butyl ester requires a single acylation step to introduce an N-terminal protecting group or the first amino acid, but leaves the amino group susceptible to premature reaction with activated esters. The hydrochloride salt is preferred for solid charging because the protonated amino group is less prone to carbon dioxide absorption and discoloration. The D-enantiomer is controlled by chiral HPLC; even small amounts of D-tyrosine tert-butyl ester can propagate to the final peptide and change biological activity, so enantiomeric purity is usually reported separately from total chromatographic purity.

Identification of the product is confirmed by proton NMR in deuterated chloroform or deuterated DMSO: the tert-butyl singlet appears near 1.40–1.45 ppm, and the α-proton and aromatic protons define the tyrosine backbone. LC-MS shows the [M+H]⁺ ion of the free base at 238.14 m/z. Specific rotation is solvent-dependent; suppliers report a value in ethanol or methanol. The free amino group can be derivatized with Fmoc-Cl in aqueous dioxane to produce Fmoc-Tyr-OtBu; in that transformation the tert-butyl ester remains stable because the derivatization conditions are mildly basic. This reaction is used to qualify the material’s amino reactivity before committing to a peptide synthesis campaign.

Cold Storage, Water Uptake, and Incompatibility Limits

Residual water in the ester is measured by Karl Fischer titration per USP <921> or ISO 760. Residual solvents are measured by headspace gas chromatography per USP <467> or Ph. Eur. 5.4. Chromatographic purity is determined by reversed-phase HPLC per USP <621> or Ph. Eur. 2.2.29, with detection at 220 nm or 254 nm. Enantiomeric purity is assigned by chiral HPLC; the method is supplier-specific because no universal pharmacopeial monograph applies to the unprotected tert-butyl ester. No universal acceptance values can be assigned to all uses. A supplier mass-balance specification may list HPLC area percent, chloride content, and residual solvents for the hydrochloride salt, but the end-use process must define internal limits.

The free-base material is hygroscopic and should be handled under nitrogen or argon in a low-relative-humidity environment. The unprotected amino group can react with atmospheric carbon dioxide, forming carbamate species that appear as additional peaks in HPLC. Long-term storage is usually at −20 °C in airtight containers with desiccant; the hydrochloride salt is less hygroscopic and is often stored at 2–8 °C. The compound should not be exposed to strong aqueous alkali because the tert-butyl ester is hydrolyzed, nor to strong acids at ambient temperature for extended periods because deprotection begins. Incompatible reagents include strong acylating agents, which react with the free amino and phenolic hydroxyl groups, and oxidizing agents that can degrade the tyrosine side chain. For anhydrous coupling, if residual water exceeds the specified limit, the material is dried under vacuum at 25–30 °C and re-tested before charging. The supplier specification should define the maximum drying temperature and the acceptable water range, as the ester can undergo thermal decomposition or aminolysis if overheated.

On solid-dispensing lines, the hydrochloride salt of L-tyrosine tert-butyl ester is generally free-flowing, but the free base can develop static charge and adhere to non-conducting liners. Bulk density and particle-size distribution are not fixed by chemistry; they depend on crystallization solvent and milling conditions. Process engineers should request lot-specific sieve data or bulk density when designing automated charging systems, because uncontrolled particle size can affect dissolution rate in DMF and the residence time required to reach a clear reaction solution.

For regulatory control, the material is classified as a chemical intermediate rather than a finished pharmaceutical product. Safety data sheets under REACH and CLP list the substance according to salt form and report hazard classifications; because the free amino group and phenolic hydroxyl are available, local effect data may differ from fully protected amino acid derivatives. Control of packaging is also process-relevant: ambient moisture ingress into multi-kilogram containers can raise the water content above the Karl Fischer specification after successive openings, so production-scale dispensing under dry nitrogen or in a glovebox is used. Analytical batches are retested after any long-term storage period that exceeds the supplier’s stability interval.